Summary by Moomoo AI
As of November 30, 2024, cansinobio's H shares and A shares have not experienced any changes in the number of shares. H shares are listed on the Hong Kong Stock Exchange with a statutory share capital of 132,670,900 shares, while A shares are listed on the Shanghai Stock Exchange's Science and Technology Innovation Board with a statutory share capital of 114,778,999 shares. The number of issued shares and treasury shares for both remains unchanged. On January 23, 2022, cansinobio passed an A-share repurchase plan intended for future employee stock ownership plans or stock-based incentives. As of November 2024, 406,098 A shares have been repurchased as treasury shares, but not yet canceled. If not used within the specified legal period, the remaining treasury A shares will be canceled. This month, cansinobio has not conducted any share repurchases or issuances, and the number of issued and treasury shares remains unchanged.
